These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4632435)

  • 1. Long-term treatment of multiple sclerosis with azathioprine.
    Swinburn WR; Liversedge LA
    J Neurol Neurosurg Psychiatry; 1973 Feb; 36(1):124-6. PubMed ID: 4632435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of azathioprine treatment in multiple sclerosis.
    Yudkin PL; Ellison GW; Ghezzi A; Goodkin DE; Hughes RA; McPherson K; Mertin J; Milanese C
    Lancet; 1991 Oct; 338(8774):1051-5. PubMed ID: 1681364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged azathioprine treatment of non-remitting multiple sclerosis.
    Rosen JA
    J Neurol Neurosurg Psychiatry; 1979 Apr; 42(4):338-44. PubMed ID: 458481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.
    Patzold U; Pocklington P
    J Neurol; 1980; 223(2):97-117. PubMed ID: 6157007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of azathioprine in relapsing-remitting multiple sclerosis.
    Goodkin DE; Bailly RC; Teetzen ML; Hertsgaard D; Beatty WW
    Neurology; 1991 Jan; 41(1):20-5. PubMed ID: 1985289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
    Haas J; Patzold U
    Nervenarzt; 1982 Feb; 53(2):105-9. PubMed ID: 6801533
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
    Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
    Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis unaffected by azathioprine in pilot study.
    Silberberg D; Lisak R; Zweiman B
    Arch Neurol; 1973 Mar; 28(3):210-2. PubMed ID: 4119511
    [No Abstract]   [Full Text] [Related]  

  • 10. A long-term double-blind controlled study on the effect of azathioprine in the treatment of multiple sclerosis.
    Minderhoud JM; Prange AJ; Luyckx GJ
    Clin Neurol Neurosurg; 1988; 90(1):25-8. PubMed ID: 3359729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul; 2(8604):179-83. PubMed ID: 2899660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.
    Patzold U; Hecker H; Pocklington P
    J Neurol Sci; 1982 Jun; 54(3):377-94. PubMed ID: 7047686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of azathioprine treatment in multiple sclerosis.
    Fratiglioni L; Siracusa GF; Amato MP; Sità D; Amaducci L
    Ital J Neurol Sci; 1988 Jun; 9(3):261-4. PubMed ID: 3403219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.